Evaluating Topical Poly-L-lactic Acid With Microneedling to Treat Perioral Wrinkles
Comparing Application Before or After Microneedling in Adults Aged 40 to 70
Led by Skincare Physicians of Chestnut Hill · Updated on 2025-12-05
26
Participants Needed
1
Research Sites
17 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating if applying topical Poly-L-lactic Acid PLLA alongside microneedling can help treat mild to moderate wrinkles around the mouth in adults aged 40 to 70. The study aims to find out if PLLA stays within the skin channels created by microneedling, whether combining these treatments is safe, and which application timingbefore or after microneedlingis more effective for improving skin appearance.
Participants will be randomly assigned to one of two groups one will have topical PLLA applied before microneedling, and the other will receive microneedling before PLLA application. Each participant will receive two treatments spaced 4 to 6 weeks apart using these methods. The study uses a single-blind design to compare outcomes between these approaches.
During the study, participants will be assessed up to 120 days after treatment using the Global Aesthetic Improvement Scale and Lemperle Wrinkle Scale, along with specialized imaging measurements. Researchers will monitor safety by tracking any adverse effects. The total participation includes treatment and follow-up visits to evaluate wrinkle improvement and skin texture changes.
CONDITIONS
Brief Title
Treatment of Perioral Wrinkles Using Topical Poly-L-lactic Acid and Microneedling Device
Research Team
J
Jessica G Labadie, MD
J
Joaninha Barbosa, BS
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
Factors
Microneedling combined with Poly-L-Lactic Acid (PLLA)
Microneedling Alone
What It Is
This arm involves microneedling of the perioral area combined with topical application of Poly-L-lactic acid (PLLA), a biostimulatory filler diluted in sterile water.
This arm uses microneedling as a standalone procedure for perioral wrinkle treatment, without the addition of topical PLLA.
Role in Trial
Evaluates whether combining PLLA with microneedling improves wrinkles compared to microneedling alone.
Serves as the comparator group to isolate the effect of microneedling alone.
Primary Use
Investigational use for perioral wrinkle reduction, with the aim of stimulating collagen and improving aesthetic appearance.
Established use for skin rejuvenation, enhancing skin texture and reducing mild wrinkles through controlled injury that stimulates repair.
How It Is Given or Performed
Microneedling device is used on the perioral region followed by application of PLLA diluted in sterile water.
Microneedling is performed on the perioral region without topical PLLA.
Evidence Status
Evidence for topical PLLA plus device-assisted delivery comes mainly from pilot studies of filler delivery via devices such as fractional lasers; direct evidence for microneedling-assisted topical PLLA is emerging.
Microneedling has established efficacy for skin rejuvenation and mild wrinkle reduction, with supporting literature for broader facial skin but limited direct studies on perioral wrinkles.
Important Limitations
The combination of topical PLLA and microneedling for wrinkle reduction remains investigational, with little published research specifically for perioral wrinkles. Safety data exists mainly for device-assisted topical delivery, and long-term results, optimal dosing, and comparative effectiveness remain under investigation.
Microneedling's effectiveness for perioral wrinkle reduction is less well studied than for facial rejuvenation and scar treatment. Outcomes may vary based on skin type and age, and optimal protocols for targeting perioral wrinkles need further validation.
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 40Years - 70Years
All Genders
Eligibility Criteria
You may qualify if you...
Males and non-pregnant, non-lactating females aged 40 to 70 years
Fitzpatrick Skin Type I-IV
Wrinkle severity graded 1 to 3 on the Lemperle scale
Able to provide written informed consent and willing to follow study procedures and visits
Signed informed consent obtained before any study-specific procedure
You will not qualify if you...
Lesions suspicious for malignancy, actinic keratosis, melasma, vitiligo, papules, nodules, or active inflammatory lesions in the treatment area
Tenderness in the treatment area
History of keloid formation or hypertrophic scarring
History of trauma or surgery to the treatment area
Scars in the treatment area
Silicone or synthetic material injections in the treatment area
Injection of fat, collagen, hyaluronic acid, or dermal fillers within the past 12 months in the treatment area
Dermabrasion or laser treatment within the past 12 months in the treatment area
Botulinum toxin injections within the past 6 months in the treatment area
Active smokers (0.5 pack/day) or quit within 3 months prior to treatment
Active, chronic, or recurrent infections
History of compromised immune system or current immunosuppressive treatment
Sensitivity to analgesics, Aquaphor, topical, or local anesthetics
Excessive sun exposure, tanning beds, or tanning creams within 30 days prior to treatment
Use of fish oil or blood thinning agents within 14 days prior to treatment
History or presence of significant bleeding disorders
Any condition limiting participation or compliance as judged by the investigator
History of drug or alcohol abuse
Any factor interfering with safety or efficacy assessment or informed consent
Treatment with investigational device or agent within 30 days before or during the study
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - Up to 120 days
Participants receive treatment involving topical Poly-L-Lactic Acid and microneedling of the perioral region in one of two sequences depending on their assigned group.
Multiple visits for treatment and assessments during the 120-day period
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Post-Marketing Study of Hyaluronic Acid Dermal Fillers Using COLD-X173 Technology for Facial Aesthetic Treatments
Observational Study on Effects of Holistic Perioral Rejuvenation Using Saypha4 Devices in Adults
Evaluating Topical Poly-L-lactic Acid With Microneedling to Treat Perioral Wrinkles
Comparing Application Before or After Microneedling in Adults Aged 40 to 70
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
A randomized, placebo-controlled, single-blinded, split-faced clinical trial evaluating the efficacy and safety of KLOX-001 gel formulation with KLOX light-emitting diode light on facial rejuvenation.
Andreas Nikolis, Steven Bernstein, Brian Kinney...